VKORC1 and Novel CYP2C9 Variation Predict Warfarin Response in Alaska Native and American Indian People
Alaska Native and American Indian (AN/AI) people have unique pharmacogene variation that may affect warfarin disposition and therapeutic response. We performed targeted genotyping for cytochrome P450 (CYP)2C9, vitamin K epoxide oxidase reductase complex subunit 1 (VKORC1), CYP4F2, CYP4F11, and gamma...
Saved in:
Main Authors: | Lindsay M. Henderson (Author), Renee F. Robinson (Author), Lily Ray (Author), Burhan A. Khan (Author), Tianran Li (Author), Denise A. Dillard (Author), Brian D. Schilling (Author), Mike Mosley (Author), Patricia L. Janssen (Author), Alison E. Fohner (Author), Allan E. Rettie (Author), Kenneth E. Thummel (Author), Timothy A. Thornton (Author), David L. Veenstra (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function
by: Alison E. Fohner, et al.
Published: (2021) -
VKORC1 variants as significant predictors of warfarin dose in Emiratis
by: Al-Mahayri ZN, et al.
Published: (2019) -
Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese population
by: Jia LQ, et al.
Published: (2017) -
VKORC1, CYP2C9 Polymorphisms and clotting factors associated with warfarin maintenance dose
by: Alisara Sangviroon
Published: (2014) -
PK/PD of warfarin associated with genetic polymorphisms of VKORC1 and CYP2C9 in indonesian patients
by: Taofik Rusdiana, et al.
Published: (2012)